Zahra Mahmoudjafari, PharmD, BCOP, clinical pharmacy manager at the University of Kansas Health System, gives her take on what payers should keep in mind when dealing with chimeric antigen receptor (CAR) T-cell therapies.
Zahra Mahmoudjafari, PharmD, BCOP, clinical pharmacy manager of hematology, bone marrow therapy, and cellular therapeutics at the University of Kansas Health System, gives her take on what payers should keep in mind when dealing with chimeric antigen receptor (CAR) T-cell therapies.
Transcript
What do you wish that more payers understood about CAR T therapies?
CAR T therapies fall under a new line of care called immune effector cell therapies and they are here to stay. They're very scientifically exciting, but I think operationally and logistically pretty challenging. I think what I would like payers to know is that while they are scientifically very, very exciting, we're still learning a lot about them and we are improving care every single day, whether it's through the different ways we select our patients or how we prioritize care.
And then additionally, I think I'd like payers to know specifically with the CAR T therapies at this time point, time is of the essence and these patients' [cases] are relapsed and refractory. And right now, our CAR T products are manufactured over the course of 3 to 4 to even 5 weeks and many times those patients don't have that kind of time. So, any delay is very impactful in their care.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More